Laguilles, Aldwin C.
HRN: 21-32-86 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/12/2022
05/19/2022
IV
600mg
Q8H
Nasal Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes